Mesenchymal stem cells to treat type 1 diabetes

被引:35
作者
Pixley, John S. [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Med, Div Rheumatol Immunol, 3601 4th St,MS 9410, Lubbock, TX 79430 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2020年 / 1866卷 / 04期
关键词
Stem cells; Mesenchymal stem cells; Type; 1; diabetes; BONE-MARROW DIFFERENTIATE; UMBILICAL-CORD; STROMAL CELLS; BETA-CELLS; IN-VITRO; ISLET TRANSPLANTATION; AUTOIMMUNE-DISEASES; INSULIN PRODUCTION; HUMAN HEPATOCYTES; CELLULAR-THERAPY;
D O I
10.1016/j.bbadis.2018.10.033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
What is clear is we are in the era of the stem cell and its potential in ameliorating human disease. Our perspective is generated from an in vivo model in a large animal that offers significant advantages (complete transplantation tolerance, large size and long life span). This review is an effort to meld our preclinical observations with others for the reader and to outline potential avenues to improve the present outlook for patients with diabetes. This effort exams the history or background of stem cell research in the laboratory and the clinic, types of stem cells, pluripotency or lack thereof based on a variety of pre-clinical investigations attempting endocrine pancreas recovery using stem cell transplantation. The focus is on the use of hematopoietic and mesenchymal stem cells. This review will also examine recent clinical experience following stem cell transplantation in patients with type 1 diabetes.
引用
收藏
页数:16
相关论文
共 108 条
[1]   Formation of human hepatocytes by human hematopoietic stem cells in sheep [J].
Almeida-Porada, G ;
Porada, CD ;
Chamberlain, J ;
Torabi, A ;
Zanjani, ED .
BLOOD, 2004, 104 (08) :2582-2590
[2]   The human-sheep chimeras as a model for human stem cell mobilization and evaluation of hemapoietic grafts' potential [J].
Almeida-Porada, Graca ;
Porada, Christopher ;
Gupta, Nicole ;
Torabi, Ali ;
Thain, David ;
Zanjani, Esmail D. .
EXPERIMENTAL HEMATOLOGY, 2007, 35 (10) :1594-1600
[3]   Thymic vasculature: organizer of the medullary epithelial compartment? [J].
Anderson, M ;
Anderson, SK ;
Farr, AG .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (07) :1105-1110
[4]  
[Anonymous], [No title captured]
[5]  
Atkinson MA, 2014, LANCET, V383, P69, DOI [10.1016/S0140-6736(13)60591-7, 10.1016/S0140-6736(18)31320-5]
[6]   Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation [J].
Auletta, JJ ;
Devecchio, JL ;
Ferrara, JLM ;
Heinzel, FP .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (12) :834-847
[7]   Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium - Feasibility, cell migration, and body distribution [J].
Barbash, IM ;
Chouraqui, P ;
Baron, J ;
Feinberg, MS ;
Etzion, S ;
Tessone, A ;
Miller, L ;
Guetta, E ;
Zipori, D ;
Kedes, LH ;
Kloner, RA ;
Leor, J .
CIRCULATION, 2003, 108 (07) :863-868
[8]   Prevention of type 1 diabetes with major histocompatibility complex-compatible and nonmarrow ablative hematopoietic stem cell transplants [J].
Beilhack, GF ;
Landa, RR ;
Masek, MA ;
Shizuru, JA .
DIABETES, 2005, 54 (06) :1770-1779
[9]   Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice [J].
Beilhack, GF ;
Scheffold, YC ;
Weissman, IL ;
Taylor, C ;
Jerabek, L ;
Burge, MJ ;
Masek, MA ;
Shizuru, JA .
DIABETES, 2003, 52 (01) :59-68
[10]   Transplanted Human Bone Marrow Progenitor Subtypes Stimulate Endogenous Islet Regeneration and Revascularization [J].
Bell, Gillian I. ;
Broughton, Heather C. ;
Levac, Krysta D. ;
Allan, David A. ;
Xenocostas, Anargyros ;
Hess, David A. .
STEM CELLS AND DEVELOPMENT, 2012, 21 (01) :97-109